| 期刊全称 | Development | |||||||||||||||||||||||||||||||||||||||
| 期刊缩写 | DEVELOPMENT | |||||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
||||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | Development’s scope covers all aspects of plant and animal development, including stem cell biology and regeneration. The single most important criterion for acceptance in Development is scientific excellence. Research papers (articles and reports) should therefore pose and test a significant hypothesis or address a significant question, and should provide novel perspectives that advance our understanding of development. We also encourage submission of papers that use computational methods or mathematical models to obtain significant new insights into developmental biology topics. Manuscripts that are descriptive in nature will be considered only when they lay important groundwork for a field and/or provide novel resources for understanding developmental processes of broad interest to the community. Development includes a Techniques and Resources section for the publication of new methods, datasets, and other types of resources. Papers describing new techniques should include a proof-of-principle demonstration that the technique is valuable to the developmental biology community; they need not include in-depth follow-up analysis. The technique must be described in sufficient detail to be easily replicated by other investigators. Development will also consider protocol-type papers of exceptional interest to the community. We welcome submission of Resource papers, for example those reporting new databases, systems-level datasets, or genetic resources of major value to the developmental biology community. For all papers, the data or resource described must be made available to the community with minimal restrictions upon publication. To aid navigability, Development has dedicated sections of the journal to stem cells & regeneration and to human development. The criteria for acceptance into these sections is identical to those outlined above. Authors and editors are encouraged to nominate appropriate manuscripts for inclusion in one of these sections. | |||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 0950-1991on-line: 1477-9129 | |||||||||||||||||||||||||||||||||||||||
| 2026最新影响因子 (2026年6月17日发布) 与上一年的差值 |
4.0↑ 0.4 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
|||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） 最后更新日期：2026-07-07 |
|
|||||||||||||||||||||||||||||||||||||||
| h-index（2021） | 302 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 5.40% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 生物-发育生物学 | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 （2026年3月24日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 2026年WOS期刊分区 （2026年6月17日发布） |
JCR学科分类
JCI学科分类
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 （2025年3月20日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2024年分区 （2023年12月27日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
|||||||||||||||||||||||||||||||||||||||
| 期刊主页 | ||||||||||||||||||||||||||||||||||||||||
| 投稿网址 | https://www.editorialmanager.com/DEVELOP | |||||||||||||||||||||||||||||||||||||||
| 编辑部地址 | COMPANY OF BIOLOGISTS LTD, BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, ENGLAND, CAMBS, CB4 4DL | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Company of Biologists Ltd | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | ENGLAND | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 371 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 56.79% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
91.07% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0950-1991%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： 平均3.0个月 |
|||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约12.5% |
|||||||||||||||||||||||||||||||||||||||
| 相关链接 |
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
|||||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
